MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 178 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $469,000 | -6.2% | 31,500 | +0.2% | 0.03% | -13.3% |
| Q2 2018 | $500,000 | +12.4% | 31,425 | +0.3% | 0.03% | +11.1% |
| Q1 2018 | $445,000 | +4.0% | 31,340 | +2.5% | 0.03% | +3.8% |
| Q4 2017 | $428,000 | +19.9% | 30,565 | +22.3% | 0.03% | +13.0% |
| Q3 2017 | $357,000 | -2.2% | 24,985 | +7.8% | 0.02% | -8.0% |
| Q2 2017 | $365,000 | +26.3% | 23,180 | +10.6% | 0.02% | +19.0% |
| Q1 2017 | $289,000 | -19.7% | 20,965 | +2.9% | 0.02% | -25.0% |
| Q4 2016 | $360,000 | -10.4% | 20,366 | -2.3% | 0.03% | -17.6% |
| Q3 2016 | $402,000 | +1.8% | 20,850 | +2.8% | 0.03% | -2.9% |
| Q2 2016 | $395,000 | +8.5% | 20,275 | +14.7% | 0.04% | -2.8% |
| Q1 2016 | $364,000 | -9.2% | 17,675 | -9.6% | 0.04% | -7.7% |
| Q4 2015 | $401,000 | +41.2% | 19,550 | +31.4% | 0.04% | -2.5% |
| Q1 2015 | $284,000 | +56.0% | 14,875 | +34.6% | 0.04% | +53.8% |
| Q4 2014 | $182,000 | – | 11,050 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |